Gene vaccination for hepatitis C.
Inchauspé
G
G
INSERM U271, Lyon, France.
D000818:Animals; D001483:Base Sequence; D005069:Evaluation Studies as Topic; D005822:Genetic Vectors / Q000235:genetics; D016679:Genome, Viral; D016174:Hepacivirus / Q000235:genetics / Q000276:immunology*; D006526:Hepatitis C / Q000276:immunology / Q000517:prevention & control*; D018936:Hepatitis C Antigens / Q000235:genetics / Q000276:immunology; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D008969:Molecular Sequence Data; D009690:Nucleic Acid Conformation; D019444:Vaccines, DNA / Q000276:immunology; D014758:Viral Core Proteins / Q000235:genetics / Q000276:immunology; D014759:Viral Envelope Proteins / Q000235:genetics / Q000276:immunology; D014761:Viral Hepatitis Vaccines / Q000276:immunology
D018936:Hepatitis C Antigens; D019444:Vaccines, DNA; D014758:Viral Core Proteins; D014759:Viral Envelope Proteins; D014761:Viral Hepatitis Vaccines; C069130:nucleocapsid protein, Hepatitis C virus